Takeda Pharmaceutical (TAK) Current Taxes (2018 - 2026)

Takeda Pharmaceutical has reported Current Taxes for 9 years, with the latest figure at $739.9 million in Q2 2026.

• On a quarterly basis, Current Taxes rose 26934.79% year-over-year to $739.9 million in Q2 2026; TTM through Jun 2026 was $739.9 million, a 26934.79% increase from a year earlier, with the FY2026 full-year figure at $624.1 million, down 28.78% from the prior year.
• Current Taxes was $739.9 million for Q2 2026 at Takeda Pharmaceutical, up from $624.1 million in the prior quarter.
• The five-year high for Current Taxes was $1.0 billion in Q2 2024, with the low at $1.5 million in Q4 2024.
• Average Current Taxes over 5 years is $296.9 million, with a median of $181.8 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Current Taxes plunged 99.74% in 2025, then jumped 26934.79% in 2026.
• Over 5 years, Current Taxes stood at $178.0 million in 2022, then plunged by 84.42% to $27.7 million in 2023, then slumped by 94.59% to $1.5 million in 2024, then surged by 1317.23% to $21.3 million in 2025, then surged by 3381.07% to $739.9 million in 2026.
• The last three Current Taxes figures came in at $739.9 million (Q2 2026), $624.1 million (Q1 2026), and $21.3 million (Q4 2025), per Business Quant data.